Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
69 hedge funds and large institutions have $57.6M invested in Genesis Healthcare, Inc. in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 34 increasing their positions, 11 reducing their positions, and 11 closing their positions.
209% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 11
56% more capital invested
Capital invested by funds: $36.8M → $57.6M (+$20.7M)
7% less funds holding
Funds holding: 74 → 69 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
V3 Capital Management
Dallas,
Texas
|
+$863K |
| 2 |
FWC
First Washington Corp
Seattle,
Washington
|
+$752K |
| 3 |
Renaissance Technologies
New York
|
+$369K |
| 4 |
JP Morgan Chase
New York
|
+$285K |
| 5 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$274K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$274K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$233K |
| 3 |
BWP
BSW Wealth Partners
Boulder,
Colorado
|
-$81.1K |
| 4 |
Goldman Sachs
New York
|
-$55.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$41K |
GEN Hedge Fund Activity: Q4 2019 in Review
69 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q4 2019, worth a combined $57.6M — up 56% from $36.8M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of GEN and 6 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 34 added.
The largest buyer was V3 Capital Management, adding an estimated $863K. The largest seller was HighTower Advisors, cutting an estimated $274K.
- 69 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q4 2019, down from 74 in Q3 2019.
- Funds reported $57.6M of Genesis Healthcare, Inc. stock for Q4 2019, up 56% quarter-over-quarter.
- 6 funds opened new Genesis Healthcare, Inc. positions in Q4 2019 and 11 closed out, a net change of -5 holders.
- The largest Genesis Healthcare, Inc. buyer in Q4 2019 was V3 Capital Management, an estimated $863K added.
- The largest Genesis Healthcare, Inc. seller in Q4 2019 was HighTower Advisors, an estimated $274K sold.
Based on aggregated 13F filings for Q4 2019.